Directorate change

Summary by AI ^BETAClose X

Victrex plc announced that David Thomas has stepped down as a Non-executive director with immediate effect due to ill health, having served since 2018. Peter Kiernan has succeeded him as Audit Committee Chair. The company expressed gratitude for Mr. Thomas's contributions.

Disclaimer*

Victrex PLC

18 May 2026

Victrex plc

Directorate change

Victrex plc ("the Company") today announces that David Thomas has informed the Board that he has stepped down as a Non-executive director of the Company with immediate effect, due to ill health. David was also Audit Committee Chair until recently, with Peter Kiernan succeeding him in that role, as previously communicated.

Dr Vivienne Cox, Chair of Victrex, said "The Board and the Company express their sincere thanks to David for his valuable contribution to Victrex since his appointment as Non-executive director in 2018".

Enquiries:

Victrex plc:

Andrew Hanson, Director of Investor Relations & Corporate Communications +44 (0) 1253 898121

+44 (0) 7809 595831

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions, focused on the strategic markets of Automotive, Aerospace, Energy & Industrial, Electronics and Medical. Every day, millions of people rely on products or applications which contain our sustainable materials, from smartphones, aeroplanes and cars to energy operations and medical devices. With over 40 years' experience, we are moving beyond the polymer into semi-finished and finished products which shape future performance for our customers and our markets, enable environmental and societal benefit for our customers and drive value for our shareholders. Find out more at www.victrexplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END